Microbot partners with US logistics provider; LIBERTY launch on track for Q4 2025

Microbot Medical Inc.

Partnered with an experienced medtech 3PL company for inventory management and order fulfillment.
Limited market release of FDA-cleared LIBERTY Endovascular Robotic System expected Q4 2025.
Broader commercial launch targeted for April 2026 at the Society of Interventional Radiology conference.
Michal Ahuvia, Director of Operations, says logistics support strengthens go-to-market efficiency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.